#23 - Neuropsychopharmacology

The tables have been turned in this one-off special of the Drug Science podcast. In this episode, Professor David Nutt is interviewed by renowned singer-songwriter – Joss Stone. Professor Nutt is the Chair of the Drug Science Scientific Committee and currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit at  …


#22 - Medical Psychedelics Working Group

On July 14th 2020, the UK’s leading independent scientific body on drugs has launched the Drug Science Medical Psychedelics Working Group. Building off the success of the Medical Cannabis Working Group, the Medical Psychedelics Working Group is a consortium of Drug Science experts, leading academics, researchers and policy specialists, supported by industry partners. The group’s aim  …


#2 - Drug testing at festivals

Professor David Nutt sits down with Fiona Measham, Anna Wade & Janine Milburn for an in depth look into why drug testing is so vital at festivals and beyond. Topics discussed include; Janine’s views following her daughters accidental overdose, how drug testing works at The Loop’s facilities, tackling the idea that the practice sends ‘mixed messages’,  …


Ketamine treatment for depression

A review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The review concludes that further restrictions around ketamine are not neccesary and provides a set of recomendations for oversight bodies that would support safe, effective, and ethical use. Read it here Related Content Medical cannabis in the UK: From  …

Ketamine as an essential medicine

A letter to The Lancet endorsing the WHO Expert Committee on Drug Dependence's conclusion that concerns over recreational ketamine abuse in no way outweigh ketamine's role as a life-saving anasthetic and essential medicine. Read it here Related Content The UK needs common sense about ketamineFebruary 10 2015 DrugScience ketamine reviewApril 3 2011

The UK needs common sense about ketamine

A version of this post was published in The Guardian Ketamine is a unique anaesthetic and analgesic that has unfortunately become a popular and harmful recreational drug. Last year, in an attempt to reduce recreational use, and on the recommendation of its Advisory Council on the Misuse of Drugs (ACMD), the UK government decided to  …


DrugScience ketamine review

The first comprehensive review of the drug since its classification, DrugScience’s ketamine review highlighted harms such as neurological and bladder damage. Read it here